Topics:

Rheumatology Network

Joint Focus: Spondyloarthritis

For the first time, two societies devoted to spondyloarthropathies have met in joint session. Rheumatology Network was on site to learn the latest from the SPARTAN-GRAPPA conference:
-- Progress toward new PsA criteria ,
-- Impending North American guidelines on spondyloarthropathies, and
-- The growing voice of PsA patients in defining outcomes.

Recent Content

Is methotrexate a good option for knee osteoarthritis? A commentary finds that the study supporting the idea provides good evidence in its favor.

In a small pilot trial, systemic sclerosis patients whose own abdominal fat cells were injected into their hands enjoyed better than a 50% improvement in hand disability. Injected cells seemed to increase growth of blood vessels.

(VIDEO) First, a live demonstration of ultrasound probe placement to examine the Achilles tendon for enthesitis. Then, a narrated series of still slides and films showing normal and abnormal views from the ultrasound monitor.

Unpublished results from Phase III trials of the uric acid inhibitor lesinurad offer promise of help for gout patients who have not reached treatment targets with allopurinol or febuxostat.

A large study of veterans reveals factors that predict which people starting methotrexate for rheumatic diseases after the age of 65 will quickly begin to show signs of liver damage.

Being overweight or obese not only increases the risk of rheumatoid arthritis developing in the first place; it also makes RA worse and decreases chances for remission.

Macrophage activation syndrome, a devastating complication of some rheumatic conditions, shows pathologic similarities to a rare hereditary condition. Genetic studies imply that their similarities may be more than coincidental.

By clicking Accept, you agree to become a member of the UBM Medica Community.